Hexanuclear cluster complexes of rhenium from radioactive isotopes have antitumor PROPERTIES

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine and pharmaceutics and concerns applications of hexanuclear rhenium cluster composed of K₄[Re₆S₈(CN)₆] based on radioactive isotopes as an antitumour agent in radiotherapy and/or photodynamic therapy.;EFFECT: invention allows lowering general exposure of an organism by precise drug delivery.;1 dwg, 2 ex